Humanized culture medium for clinical expansion of human erythroblasts

Giovanni Migliaccio, Massimo Sanchez, Francesca Masiello, Valentina Tirelli, Lilian Varricchio, Carolyn Whitsett, Anna Rita Migliaccio

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Abstract

Ex vivo-generated erythroblasts represent alternative transfusion products. However, inclusion of bovine components in media used for their growth precludes clinical use, highlighting the importance of developing culture media based on pharmaceutical grade reagents. In addition, because adult blood generates ex vivo lower numbers of erythroblasts than cord blood, cord blood has been proposed as the source of choice for ex vivo erythroblast production. To clarify the potential of adult blood to generate erythroblasts ex vivo, experiments were designed to identify growth factors [stem cell factor (SCF), interleukin-3 (IL-3), erythropoietin (EPO), and/or thrombopoietin (TPO)] and the optimal concentration and addition schedule of hormones (dexamethasone and estradiol) sustaining maximal erythroid amplification from adult blood mononuclear cells (MNC) using media with serum previously defined as human erythroid massive amplification culture (HEMAser). Adult MNC stimulated with SCF and IL-3 in combination with EPO generated a 6-12-fold increase in erythroid cells while TPO was ineffective. Dexamethasone and estradiol (both at 10-6 M) exerted partially overlapping but nonredundant functions. Dexamethasone was indispensable in the first 10 days of culture while estradiol was required from day 10 on. The growth factor and hormone combinations identified in HEMAser were then used to formulate a media composed of dialyzed pharmaceutical grade human albumin, human albumin-lipid liposomes, and iron-saturated recombinant human tranferrin (HEMAdef). HEMAdef sustained erythroid amplification as efficiently as HEMAser for cord blood MNC and 10-fold higher than HEMAser for adult blood MNC. In fact, the numbers of erythroblasts generated in HEMAdef by adult MNC were similar to those generated by cord blood MNC. In conclusion, this study identifies growth factors, hormone combinations, and human protein-based media that allow similar levels of ex vivo erythroid expansion from adult and cord blood MNC, paving the way to evaluate adult blood as a source of ex vivo-expanded erythroblasts for transfusion.

Original languageEnglish
Pages (from-to)453-469
Number of pages17
JournalCell Transplantation
Volume19
Issue number4
DOIs
StatePublished - 2010
Externally publishedYes

Keywords

  • Erythroblasts
  • Growth factors
  • Human albumin
  • Human erythroid massive amplification (HEMA) culture
  • Transfusion

Fingerprint

Dive into the research topics of 'Humanized culture medium for clinical expansion of human erythroblasts'. Together they form a unique fingerprint.

Cite this